Cell cycle, CDKs and cancer: a changing paradigm

Malumbres, Marcos, Barbacid, Mariano·2009·Nature Reviews Cancer

Cited by (1,005)

Items 901–1,000 of 1,005

  1. Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and Its Nuclear Accumulation Suppresses Gastric Tumorigenesis
    Long‐Long Cao, Jiechao Zhou, Junrong Zhang, Sijin Wu, Xintao Yang, Xin Zhao, Huifang Li, Ming Luo, Qian Yu, Guang‐Tan Lin et al. · 2015 · Clinical Cancer Research
  2. Induction of Cell Cycle Arrest and Apoptosis by Physcion, an Anthraquinone Isolated From Rhubarb (Rhizomes of Rheum tanguticum), in MDA-MB-231 Human Breast Cancer Cells
    Ji-Young Hong, Hwa‐Jin Chung, Song Yi Bae, Trinh Nam Trung, KiHwan Bae, Sang Kook Lee · 2014 · Journal of Cancer Prevention
  3. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer
    Yan Lv, Huan Li, Fengling Li, Peishu Liu, Xinrui Zhao · 2017 · Cancer Biotherapy and Radiopharmaceuticals
  4. The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells
    Imaobong Christopher Etti, Rasedee Abdullah, Arifah Abdul Kadir, Najihah Mohd Hashim, Swee Keong Yeap, Mustapha Umar Imam, Faiqah Binti Ramli, Ibrahim Malami, Kian Lim Lam, Ubong Etti et al. · 2017 · PLoS ONE
  5. CDK4 Regulates Lysosomal Function and mTORC1 Activation to Promote Cancer Cell Survival
    Martínez-Carreres, Laia, Puyal, Julien, Leal-Esteban, Lucía C., Orpinell, Meritxell, Castillo-Armengol, Judit, Giralt, Albert, Dergai, Oleksandr, Moret, Catherine, Barquissau, Valentin, Nasrallah, Anita et al. · 2019 · Cancer Research
  6. The therapeutic potential of PROTACs
    Andrew B. Benowitz, Katherine L. Jones, John D. Harling · 2020 · Expert Opinion on Therapeutic Patents
  7. CDK Family PROTAC Profiling Reveals Distinct Kinetic Responses and Cell Cycle–Dependent Degradation of CDK2
    Kristin M. Riching, Marie K. Schwinn, James D. Vasta, Matthew B. Robers, Thomas Machleidt, Marjeta Urh, Danette L. Daniels · 2020 · SLAS DISCOVERY
  8. Targeting cyclin‐dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies
    Mohd Yousuf, Anas Shamsi, Aarfa Queen, Mohd Shahbaaz, Parvez Κhan, Afzal Hussain, Mohamed Fahad Alajmi, Qazi Mohd Rizwanul Haque, Md. Imtaiyaz Hassan · 2021 · Journal of Cellular Biochemistry
  9. Circular RNAs in cell cycle regulation: Mechanisms to clinical significance
    Wei Xiao, Juan Li, June Hu, Lingzhi Wang, Jiang Rong Huang, Gautam Sethi, Zhaowu Ma · 2021 · Cell Proliferation
  10. Cell Cycle Stage Classification Using Phase Imaging with Computational Specificity
    Yuchen R. He, Shenghua He, Mikhail E. Kandel, Young Jae Lee, Chenfei Hu, Nahil Sobh, Mark A. Anastasio, Gabriel Popescu · 2022 · ACS Photonics
  11. Injury-specific factors in the cerebrospinal fluid regulate astrocyte plasticity in the human brain
    Swetlana Sirko, Christian Schichor, Patrizia Della Vecchia, Fabian Metzger, Giovanna Sonsalla, Tatiana Simon, Martina Bürkle, Sofia Kalpazidou, Jovica Ninkovic, Giacomo Masserdotti et al. · 2023 · Nature Medicine
  12. Aberrant Expression of Cyclin D1 in Cancer
    Kazushi Inoue, Elizabeth A. Fry · 2015 · Signal Transduction Insights
  13. Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant glioma
    Christine K. Cheng, William Clay Gustafson, Elizabeth M. Charron, Benjamin T. Houseman, Eli R. Zunder, Andrei Goga, Nathanael S. Gray, Brian A. Pollok, Scott A. Oakes, Charles David James et al. · 2012 · Proceedings of the National Academy of Sciences
  14. Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation
    Bo Zhai, Xian Jiang, Changjun He, Dali Zhao, Lixin Ma, Lishan Xu, Hongchi Jiang, Xueying Sun · 2014 · Tumor Biology
  15. Chemopreventive Effects of Licorice and Its Components
    Ann M. Bode, Zigang Dong · 2015 · Current Pharmacology Reports
  16. Pathways for Genome Integrity in G2 Phase of the Cell Cycle
    Arne Nedergaard Kousholt, Tobias Menzel, Claus Storgaard Sørensen · 2012 · Biomolecules
  17. Cilia Disassembly with Two Distinct Phases of Regulation
    Zhangfeng Hu, Yinwen Liang, Wei He, Junmin Pan · 2015 · Cell Reports
  18. The ZEB1 Transcription Factor Acts in a Negative Feedback Loop with miR200 Downstream of Ras and Rb1 to Regulate Bmi1 Expression
    Yongqing Liu, Ester Sànchez‐Tilló, Xiaoqin Lu, Li Feng Huang, Brian F. Clem, Sucheta Telang, Alfred B. Jenson, Míriam Cuatrecasas, Jason Alan Chesney, Antonio A. Postigo et al. · 2013 · Journal of Biological Chemistry
  19. Structural basis of divergent cyclin‐dependent kinase activation by Spy1/RINGO proteins
    Denise A McGrath, Bre‐Anne Fifield, Aimee H. Marceau, Sarvind Mani Tripathi, Lisa Ann Porter, Seth M. Rubin · 2017 · The EMBO Journal
  20. Role of cell cycle regulators in adipose tissue and whole body energy homeostasis
    Isabel C. López‐Mejía, Judit Castillo‐Armengol, Sandrine Lagarrigue, Lluis Fajas A · 2017 · Cellular and Molecular Life Sciences
  21. A selective cyclin-dependent kinase 4, 6 dual inhibitor, Ribociclib (LEE011) inhibits cell proliferation and induces apoptosis in aggressive thyroid cancer
    Hyun Joo Lee, Woo Kyung Lee, Chan Woo Kang, Cheol Ryong Ku, Yoon Hee Cho, Eun Jig Lee · 2018 · Cancer Letters
  22. Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1
    Zhengyuan Zhang, Mingyang Shen, Guangrong Zhou · 2018 · Biochemical and Biophysical Research Communications
  23. Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors
    Boya Liu, Xiaoyan He, Ren‐Xi Zhuo, Si‐Xue Cheng · 2018 · Journal of Controlled Release
  24. A five-gene signature predicts overall survival of patients with papillary renal cell carcinoma
    Ze Gao, Dong Zhang, Yi Duan, Lei Yan, Yidong Fan, Zhiqing Fang, Zhaoxu Liu · 2019 · PLoS ONE
  25. Hydrostatic pressure promotes endothelial tube formation through aquaporin 1 and Ras-ERK signaling
    Daisuke Yoshino, Kenichi Funamoto, Kakeru Sato, Kenry Kenry, Masaaki Sato, Chwee Teck Lim · 2020 · Communications Biology
  26. MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F transcription factor 5.
    Xiupeng Xu, Ning Cai, Tongle Zhi, Zhongyuan Bao, Dong Wang, Yinlong Liu, Kuan Jiang, Liang Fan, Jing Ji, Ning Liu · 2017 · PubMed Central
  27. A phase 1 study of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor in Chinese patients with advanced breast cancer
    Pin Zhang, Binghe Xu, Lin Gui, Wenna Wang, Meng Xiu, Xiao Zhang, Guilan Sun, Xiaoyu Zhu, Jianjun Zou · 2021 · Biomarker Research
  28. New Castanospermine Glycoside Analogues Inhibit Breast Cancer Cell Proliferation and Induce Apoptosis without Affecting Normal Cells
    Allan, Ghada, Ouadid-Ahidouch, Halima, Sanchez-Fernandez, Elena M., Risquez-Cuadro, Rocío, Fernandez, José M. Garcia, Ortiz-Mellet, Carmen, Ahidouch, Ahmed · 2013 · PLoS ONE
  29. Cyclin‐dependent kinases: Masters of the eukaryotic universe
    Aleksandra J. Pluta, Cécilia Studniarek, Shona Murphy, Chris J. Norbury · 2023 · Wiley Interdisciplinary Reviews - RNA
  30. A Dynamic Gene Regulatory Network Model That Recovers the Cyclic Behavior of Arabidopsis thaliana Cell Cycle
    Elizabeth Ortiz-Gutiérrez, Karla V. García-Cruz, Eugenio M. Azpeitia, Aaron Castillo, María de la Paz Sánchez, Elena R Alvarez-Buylla · 2015 · PLoS Computational Biology
  31. Delayed cell cycle pathway modulation facilitates recovery after spinal cord injury
    Junfang Wu, Bogdan A. Stoica, Michael Dinizo, Ahdeah Pajoohesh‐Ganji, Chun-Shu Piao, Alan I. Faden · 2012 · Cell Cycle
  32. New Therapeutic Targets in Soft Tissue Sarcoma
    Elizabeth G. Demicco, Robert G. Maki, Dina Chelouche Lev, Alexander J. Lazar · 2012 · Advances in Anatomic Pathology
  33. Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1
    Roger Badía, Guillem Angulo, Eva Riveira‐Muñoz, Maria Pujantell, Teresa Puig, Cristina Ramirez, Javier Torres‐Torronteras, Ramón Martí, Eduardo Pauls, Bonaventura Clotet et al. · 2015 · Journal of Antimicrobial Chemotherapy
  34. Regulation of yeast forkhead transcription factors and FoxM1 by cyclin-dependent and polo-like kinases
    Hiroshi Murakami, Hirofumi Aiba, Makoto Nakanishi, Yuko Murakami‐Tonami · 2010 · Cell Cycle
  35. Translational control of cyclins
    Woan‐Yuh Tarn, Ming‐Chih Lai · 2011 · Cell Division
  36. Identification of novel,in vivoactive Chk1 inhibitors utilizing structure guided drug design
    Andrew J. Massey, S.P. Stokes, Helen L. Browne, Nicolas Foloppe, Andreá Fiumana, Simon Scrace, Mandy Fallowfield, Simon T. Bedford, Paul Webb, Lisa M. Baker et al. · 2015 · Oncotarget
  37. Ciliogenesis and the DNA damage response: a stressful relationship
    Colin A. Johnson, Spencer James Collis · 2016 · Cilia
  38. Cyclin-Dependent Kinase 14 Promotes Cell Proliferation, Migration and Invasion in Ovarian Cancer by Inhibiting Wnt Signaling Pathway
    Jun Ou-Yang, Li-Hong Huang, Xiangxiu Sun · 2016 · Gynecologic and Obstetric Investigation
  39. MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells
    Luciano Mazzoccoli, Marcela Cristina Robaina, Alexandre Gustavo Apa, Martín Bonamino, Luciana Wernersbach Pinto, Eduardo Queiroga, Carlos E. Bacchi, Claudete Esteves Klumb · 2018 · Journal of Cancer Research and Clinical Oncology
  40. Functional Role of microRNA-23b-3p in Cancer Biology
    Ilaria Grossi, Alessandro Salvi, Gian Luca Baiocchi, Nazario Portolani, Giuseppina De Petro · 2018 · MicroRNA
  41. ReishiMax inhibits mTORC1/2 by activating AMPK and inhibiting IGFR/PI3K/Rheb in tumor cells
    Didem Şöhretoğlu, Chao Zhang, Jun Luo, Shile Huang · 2019 · Signal Transduction and Targeted Therapy
  42. Antitumor Activity of Ohmyungsamycin A through the Regulation of the Skp2-p27 Axis and MCM4 in Human Colorectal Cancer Cells
    Woong Sub Byun, Sunghwa Kim, Yern‐Hyerk Shin, Won Kyung Kim, Dong‐Chan Oh, Sang Kook Lee · 2020 · Journal of Natural Products
  43. Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions
    Viktorija Jurić, Brona M. Murphy · 2020 · Cancer Drug Resistance
  44. Small Molecule CDK Inhibitors for the Therapeutic Management of Cancer
    Bharat Goel, Nancy Tripathi, Nivedita Bhardwaj, Shreyans Kumar Jain · 2020 · Current Topics in Medicinal Chemistry
  45. Indazole scaffold: a generalist for marketed and clinical drugs
    Yaquan Cao, Chunying Luo, Yang Pu, Pan Li, Chunli Wu · 2020 · Medicinal Chemistry Research
  46. Integrated Screens Identify CDK1 as a Therapeutic Target in Advanced Gastrointestinal Stromal Tumors
    Xiaojing Lu, Yuzhi Pang, Hui Cao, Xiaoxiao Liu, Lin Tu, Yanying Shen, Xiaona Jia, Jen‐Chieh Lee, Yuexiang Wang · 2021 · Cancer Research
  47. Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis
    Jinhang Hu, Jiangluqi Song, Zhishu Tang, Simin Wei, Lin Chen, Rui Zhou · 2021 · European Journal of Pharmacology
  48. Design, synthesis, anticancer evaluation and molecular docking study of novel 2,4-dichlorophenoxymethyl-based derivatives linked to nitrogenous heterocyclic ring systems as potential CDK-2 inhibitors
    Amira A. El‐Sayed, Eman Samir Nossier, Abdulrahman Abdulaziz Almehizia, Abd El‐Galil E. Amr · 2021 · Journal of Molecular Structure
  49. Tumor-suppressive effects of CDK8 in endometrial cancer cells
    Weiting Gu, Chenguang Wang, Weihua Li, Fu-Ning Hsu, Lifeng Tian, Jie Zhou, Cunzhong Yuan, Xiao-Jun Xie, Tao Jiang, Sankar Addya et al. · 2013 · Cell Cycle
  50. E2F Inhibition Synergizes with Paclitaxel in Lung Cancer Cell Lines
    Courtney A. Kurtyka, Lu Chen, William Douglas Cress · 2014 · PLoS ONE
  51. Cyclin D1 and cdk4 mediate development of neurologically destructive oligodendroglioma
    Ciznadija, Daniel, Liu, Yuhui, Pyonteck, Stephanie M., Holland, Eric C., Koff, Andrew · 2011 · Cancer Research
  52. Induction of Tumor Cell Death through Targeting Tubulin and Evoking Dysregulation of Cell Cycle Regulatory Proteins by Multifunctional Cinnamaldehydes
    Amrita Abhay Nagle, Fei-Fei Gan, Gavin Jones, Choon Leng So, Geoffrey Wells, Eng‐Hui Chew · 2012 · PLoS ONE
  53. Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes
    Ryan A. Metcalf, Shuchun Zhao, Matthew W. Anderson, Zhi Shun Lu, Ilana B. Galperin, Robert J. Marinelli, Athena M. Cherry, Izidore S. Lossos, Yasodha Natkunam · 2010 · Modern Pathology
  54. MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1
    Qiang Zhang, Yonghui Yuan, Jianchun Cui, Tingting Xiao, Daqing Jiang · 2015 · Journal of Cancer
  55. Dendrobium candidum inhibits MCF-7 cells proliferation by inducing cell cycle arrest at G2/M phase and regulating key biomarkers
    Xin Hu, Jing Sun, Xueqi Fu, Yongsen Wang, Ye Liu, Yidi Guo, Huo Bo, Jun Sheng · 2015 · OncoTargets and Therapy
  56. Quercetin reduces cyclin D1 activity and induces G1 phase arrest in HepG2 cells
    Jin Zhou, LU Li, LI FANG, Hua Xie, Wenxiu Yao, Xiang Zhou, Zhujuan Xiong, Li Wang, Zhixi Li, Feng Luo · 2016 · Oncology Letters
  57. Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.
    Haiqi Lu, Guangliang Li, Chenyi Zhou, Wei Jin, Xiaoling Qian, Zejing Wang, Hongming Pan, Hongchuan Jin, Xian Wang · 2016 · PubMed Central
  58. KLF15 Inhibits Cell Proliferation in Gastric Cancer Cells via Up-Regulating CDKN1A/p21 and CDKN1C/p57 Expression
    Chongqi Sun, Pei Ma, Yanfen Wang, Weitao Liu, Qinnan Chen, Yutian Pan, Chenhui Zhao, Ying-Chen Qian, Jie Liu, Wei Li et al. · 2017 · Digestive Diseases and Sciences
  59. Crambescidin 800, Isolated from the Marine Sponge Monanchora viridis, Induces Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells
    Sumi Shrestha, Anabel Sorolla, Jane Fromont, Pilar Blancafort, Gavin R. Flematti · 2018 · Marine Drugs
  60. Natural products as new antimitotic compounds for anticancer drug development
    Carlos Roberto Koscky Paier, Sarah Sant’Anna Maranhão, Teiliane Rodrigues Carneiro, Lı́dia Moreira Lima, Danilo D. Rocha, Renan da Silva Santos, Kaio Moraes de Farias, Manoel Odorico de Moraes-Filho, Cláudia Pessoa · 2018 · Clinics
  61. PCTK Proteins: The Forgotten Brain Kinases?
    Adam R. Cole · 2009 · Neurosignals
  62. An Integrated Chemical Biology Approach Provides Insight into Cdk2 Functional Redundancy and Inhibitor Sensitivity
    Aude Echalier, Emilie Cot, Alain Camasses, Elsie Hodimont, François Hoh, Philippe Jay, Felix B. Sheinerman, Liliana Krasińska, Daniel Fisher · 2012 · Chemistry & Biology
  63. Human phosphatase CDC14A is recruited to the cell leading edge to regulate cell migration and adhesion
    Nan‐Peng Chen, Borhan Uddin, Renate Voit, Elmar Schiebel · 2016 · Proceedings of the National Academy of Sciences
  64. Antitumor action of CDK inhibitor LS-007 as a single agent and in combination with ABT-199 against human acute leukemia cells
    Shao Ping Xie, Hui Jiang, Xiaowen Zhai, Wei Qiang Fan, Shudong Wang, Jian Ding, Yi Chen · 2016 · Acta Pharmacologica Sinica
  65. Oncogenic action of the exosome cofactor RBM7 by stabilization of CDK1 mRNA in breast cancer
    Pei-Wen Xi, Xu Zhang, Lei Zhu, Xinyuan Dai, Lin Cheng, Yue Hu, Liang Shi, Ji‐Fu Wei, Qiang Ding · 2020 · npj Breast Cancer
  66. Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis
    Alvin H.K. Cheung, Chris Ho‐Lam Hui, Kit Yee Wong, Xiaoli Liu, Bonan Chen, Wei Kang, Ka Fai To · 2022 · International Journal of Cancer
  67. CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
    Elana Thieme, Nur Bruss, Duanchen Sun, Edward C. Dominguez, Daniel J. Coleman, Tingting Liu, Carly Roleder, Melissa Martinez, Krystine Garcia‐Mansfield, Brian J. Ball et al. · 2023 · Molecular Cancer
  68. Cdk2-Null Mice Are Resistant to ErbB-2-Induced Mammary Tumorigenesis
    Dipankar Ray, Yasuhisa Terao, Konstantin T. Christov, Philipp Kaldis, Hiroaki Kiyokawa · 2011 · Neoplasia
  69. Association between Gene Expression Profile, Proliferation and Metastasis in Uveal Melanoma
    Michael D. Onken, Lori A. Worley, J. William Harbour · 2010 · Current Eye Research
  70. Microarray Gene Expression Analysis of Tumorigenesis and Regional Lymph Node Metastasis in Laryngeal Squamous Cell Carcinoma
    Meng Lian, Jugao Fang, Demin Han, Hongzhi Ma, Ling Feng, Ru Wang, Fan Yang · 2013 · PLoS ONE
  71. Luteolin Induced-growth Inhibition and Apoptosis of Human Esophageal Squamous Carcinoma Cell Line Eca109 Cells in vitro
    Tingting Wang, Shaokang Wang, Gui-Ling Huang, Guiju Sun · 2012 · Asian Pacific Journal of Cancer Prevention
  72. Phosphorylation Events Catalyzed by Major Cell Signaling Proteins Differ in Response to Thermal and Osmotic Stress among Native (Mytilus californianusandMytilus trossulus) and Invasive (Mytilus galloprovincialis) Species of Mussels
    Tyler G. Evans, George N. Somero · 2010 · Physiological and Biochemical Zoology
  73. Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo
    Mingxia Zhao, Hongyu Ren, Jin Keun Chang, Diqin Zhang, Yating Yang, Yong He, Chuanmin Qi, Huabei Zhang · 2016 · European Journal of Medicinal Chemistry
  74. The awakening of the CDK10/Cyclin M protein kinase
    Vincent J. Guen, Carly Gamble, Jacqueline A. Lees, Pierre Colas · 2017 · Oncotarget
  75. RNA interference against TMEM97 inhibits cell proliferation, migration, and invasion in glioma cells
    Guanzhong Qiu, Wei Sun, Yongxiang Zou, Zheng Cai, Peng Wang, Xianbin Lin, Jinxiang Huang, Lei Jiang, Xuehua Ding, Guohan Hu · 2015 · Tumor Biology
  76. A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer
    Burak Bi̇lgi̇n, Mehmet Alı Nahıt Şendur, Didem Şener Dede, Muhammed Bülent Akıncı, Bülent Yalçın · 2017 · Current Medical Research and Opinion
  77. Actein induces autophagy and apoptosis in human bladder cancer by potentiating ROS/JNK and inhibiting AKT pathways
    Lü Ji, Bing Zhong, Xi Jiang, Fei Mao, Gang Liu, Bin Song, Cheng-Yuan Wang, Yong Jiao, Jiang-Ping Wang, Zhi-Bin Xu et al. · 2017 · Oncotarget
  78. ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer
    Jordan M. Reese, Elizabeth S. Bruinsma, David G. Monroe, Vivian C. Negron, Vera Jean Suman, James N. Ingle, Matthew Philip Goetz, John R. Hawse · 2017 · Oncotarget
  79. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells
    Ke‐Hung Tsui, Kun‐Chun Chiang, Yu‐Hsiang Lin, Kang‐Shuo Chang, Tsui‐Hsia Feng, Horng‐Heng Juang · 2017 · Cancer Medicine
  80. Hesperetin Induces Apoptosis in Human Glioblastoma Cells via p38 MAPK Activation
    Qiang Li, Ziwei Miao, Rui Wang, Jun Yang, Dianbao Zhang · 2019 · Nutrition and Cancer
  81. Interstitial lung disease in patients treated with Cyclin-Dependent Kinase 4/6 inhibitors: A systematic review and meta-analysis of randomized controlled trials
    Yi Zhang, Zhuo Ma, Ximu Sun, Xin Feng, Zhuoling An · 2022 · The Breast
  82. Concise Review: Early Embryonic Erythropoiesis: Not so Primitive After All
    Margaret H. Baron · 2013 · Stem Cells
  83. ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway
    Ping Lin, Xicai Sun, Tian Feng, Haifeng Zou, Ying Jiang, Zijun Liu, Dandan Zhao, Xiaoguang Yu · 2011 · Molecular and Cellular Biochemistry
  84. Impaired tissue growth is mediated by checkpoint kinase 1 (CHK1) in the integrated stress response
    Elke Malzer, Marie‐Louise Daly, Aileen M. Moloney, Timothy J. Sendall, Sally E. Thomas, Edward J. Ryder, Hyung Don Ryoo, Damian C. Crowther, David A. Lomas, Stefan John Marciniak · 2010 · Journal of Cell Science
  85. Activation of CDC25A phosphatase is limited by CDK2/cyclin A-mediated feedback inhibition
    Jennifer P. Ditano, Nandini Sakurikar, Alan R. Eastman · 2021 · Cell Cycle
  86. Discovery of LL-K8-22: A Selective, Durable, and Small-Molecule Degrader of the CDK8-Cyclin C Complex
    Mingyu Wang, Rongkun Lin, Jiacheng Li, Yuying Suo, Jing Gao, Liping Liu, Liyuan Zhou, Yicheng Ni, Ziqun Yang, Jie Zheng et al. · 2023 · Journal of Medicinal Chemistry
  87. Dichloroacetate alters Warburg metabolism, inhibits cell growth, and increases the X-ray sensitivity of human A549 and H1299 NSC lung cancer cells
    K. Tan–Allen, Helen Chin-Sinex, Thomas DeLuca, Joseph R. Pomerening, Jeremy Sherer, John B. Watkins, John Foley, Jerry M. Jesseph, Marc S. Mendonca · 2015 · Free Radical Biology and Medicine
  88. 7,3′,4′-Trihydroxyisoflavone Inhibits Epidermal Growth Factor-induced Proliferation and Transformation of JB6 P+ Mouse Epidermal Cells by Suppressing Cyclin-dependent Kinases and Phosphatidylinositol 3-Kinase
    Dong Eun Lee, Ki Won Lee, Nu Ry Song, Sang Kwon Seo, Yong-Seok Heo, Nam Joo Kang, Ann M. Bode, Hyong Joo Lee, Zigang Dong · 2010 · Journal of Biological Chemistry
  89. Mechanistic elucidation of apoptosis and cell cycle arrest induced by 5-hydroxymethylfurfural, the important role of ROS-mediated signaling pathways
    Ling Zhao, Jianyu Su, Lin Li, Jianping Chen, Song‐Qing Hu, Xia Zhang, Tianfeng Chen · 2014 · Food Research International
  90. Drosophila FMRP participates in the DNA damage response by regulating G2/M cell cycle checkpoint and apoptosis
    Wei Liu, Fangfang Jiang, Xiaolin Bi, Yongqing Zhang · 2012 · Human Molecular Genetics
  91. Novel Interactions between FOXM1 and CDC25A Regulate the Cell Cycle
    Con Sullivan, Youhong Liu, Jingjing Shen, Curtis Adam, Newman Christina, Janet M. Hock, Xiong Li · 2012 · PLoS ONE
  92. MicroRNA-576-3p Inhibits Proliferation in Bladder Cancer Cells by Targeting Cyclin D1
    Zhen Chang Liang, Shiqi Li, Xin Xu, Xianglai Xu, Xiao Wang, Jian Wu, Yi Zhu, Zhenghui Hu, Yiwei Lin, Yeqing Mao et al. · 2014 · Molecules and Cells
  93. Principles of K-Ras effector organization and the role of oncogenic K-Ras in cancer initiation through G1 cell cycle deregulation
    Ruth Nussinov, Chung‐Jung Tsai, Serena Muratcioğlu, Hyunbum Jang, Attila Gürsoy, Özlem Keskin · 2015 · Expert Review of Proteomics
  94. STAR syndrome-associated CDK10/Cyclin M regulates actin network architecture and ciliogenesis
    Vincent J. Guen, Carly Gamble, Dahlia E. Perez, Sylvie Bourassa, H. Zappel, Jutta Gärtner, Jacqueline A. Lees, Pierre Colas · 2016 · Cell Cycle
  95. Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics
    Teresa L. Helsten, Shumei Kato, Maria Clemence Schwaederle, Brett N. Tomson, Timon P.H. Buys, Sheryl Krevsky Elkin, Jennifer L. Carter, Razelle Kurzrock · 2016 · Molecular Cancer Therapeutics
  96. A CDK2 activity signature predicts outcome in CDK2-low cancers
    Sean R. McCurdy, Marek Pacal, Mohammad Abd El-Rahman Ahmad, Rod Bremner · 2016 · Oncogene
  97. Current status of mathematical modeling of cancer – From the viewpoint of cancer hallmarks
    Shigeyuki Magi, Kazunari Iwamoto, Mariko Okada · 2017 · Current Opinion in Systems Biology
  98. CoA synthase regulates mitotic fidelity via CBP-mediated acetylation
    Chao‐Chieh Lin, Mayumi Kitagawa, Xiaohu Tang, Ming-Hsin Hou, Jianli Wu, Dan Chen Qu, Vinayaka Srinivas, Xiaojing Liu, J. Will Thompson, Bernard Mathey-Prévôt et al. · 2018 · Nature Communications
  99. Hinokiflavone induces apoptosis in melanoma cells through the ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion
    Shuping Yang, Yange Zhang, Yi Luo, Bocheng Xu, Yuqin Yao, Yuanle Deng, Fangfang Yang, Tinghong Ye, Gang Wang, Zhiqiang Cheng et al. · 2018 · Biomedicine & Pharmacotherapy
  100. Nitrogen Mustards as Anticancer Chemotherapies: Historic Perspective, Current Developments and Future Trends
    Benjamín Diethelm‐Varela, Yong Ai, Dongdong Liang, Fengtian Xue · 2019 · Current Topics in Medicinal Chemistry